Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 100 entries
Sorted by: Best Match Show Resources per page
Optical pumping technique for measuring small nuclear quadrupole shifts in 1S0 atoms and testing spatial isotropy.

Physical review. A, General physics

Fortson EN, Heckel BR, Jacobs JP, Lamoreaux SK, Raab FJ.
PMID: 9901347
Phys Rev A Gen Phys. 1989 Feb 01;39(3):1082-1111. doi: 10.1103/physreva.39.1082.

No abstract available.

Cite
Fortson EN, Heckel BR, Jacobs JP, et al. Optical pumping technique for measuring small nuclear quadrupole shifts in 1S0 atoms and testing spatial isotropy. Phys Rev A Gen Phys. 1989;39(3):1082-1111doi: 10.1103/physreva.39.1082.
Fortson, E. N., Heckel, B. R., Jacobs, J. P., Lamoreaux, S. K., & Raab, F. J. (1989). Optical pumping technique for measuring small nuclear quadrupole shifts in 1S0 atoms and testing spatial isotropy. Physical review. A, General physics, 39(3), 1082-1111. https://doi.org/10.1103/physreva.39.1082
Fortson, et al. "Optical pumping technique for measuring small nuclear quadrupole shifts in 1S0 atoms and testing spatial isotropy." Physical review. A, General physics vol. 39,3 (1989): 1082-1111. doi: https://doi.org/10.1103/physreva.39.1082
Fortson EN, Heckel BR, Jacobs JP, Lamoreaux SK, Raab FJ. Optical pumping technique for measuring small nuclear quadrupole shifts in 1S0 atoms and testing spatial isotropy. Phys Rev A Gen Phys. 1989 Feb 01;39(3):1082-1111. doi: 10.1103/physreva.39.1082. PMID: 9901347.
Copy Download .nbib Format: NLM
A quantum enhanced search for dark matter axions.

Nature

Backes KM, Palken DA, Kenany SA, Brubaker BM, Cahn SB, Droster A, Hilton GC, Ghosh S, Jackson H, Lamoreaux SK, Leder AF, Lehnert KW, Lewis SM, Malnou M, Maruyama RH, Rapidis NM, Simanovskaia M, Singh S, Speller DH, Urdinaran I, Vale LR, van Assendelft EC, van Bibber K, Wang H.
PMID: 33568823
Nature. 2021 Feb;590(7845):238-242. doi: 10.1038/s41586-021-03226-7. Epub 2021 Feb 10.

The manipulation of quantum states of light

Cite
Backes KM, Palken DA, Kenany SA, et al. A quantum enhanced search for dark matter axions. Nature. 2021;590(7845):238-242doi: 10.1038/s41586-021-03226-7.
Backes, K. M., Palken, D. A., Kenany, S. A., Brubaker, B. M., Cahn, S. B., Droster, A., Hilton, G. C., Ghosh, S., Jackson, H., Lamoreaux, S. K., Leder, A. F., Lehnert, K. W., Lewis, S. M., Malnou, M., Maruyama, R. H., Rapidis, N. M., Simanovskaia, M., Singh, S., Speller, D. H., Urdinaran, I., Vale, L. R., van Assendelft, E. C., van Bibber, K., & Wang, H. (2021). A quantum enhanced search for dark matter axions. Nature, 590(7845), 238-242. https://doi.org/10.1038/s41586-021-03226-7
Backes, K M, et al. "A quantum enhanced search for dark matter axions." Nature vol. 590,7845 (2021): 238-242. doi: https://doi.org/10.1038/s41586-021-03226-7
Backes KM, Palken DA, Kenany SA, Brubaker BM, Cahn SB, Droster A, Hilton GC, Ghosh S, Jackson H, Lamoreaux SK, Leder AF, Lehnert KW, Lewis SM, Malnou M, Maruyama RH, Rapidis NM, Simanovskaia M, Singh S, Speller DH, Urdinaran I, Vale LR, van Assendelft EC, van Bibber K, Wang H. A quantum enhanced search for dark matter axions. Nature. 2021 Feb;590(7845):238-242. doi: 10.1038/s41586-021-03226-7. Epub 2021 Feb 10. PMID: 33568823.
Copy Download .nbib Format: NLM
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.

Molecular oncology

Sultan M, Nearing JT, Brown JM, Huynh TT, Cruickshank BM, Lamoureaux E, Vidovic D, Dahn ML, Fernando W, Coyle KM, Giacomantonio CA, Langille MGI, Marcato P.
PMID: 33932086
Mol Oncol. 2021 Aug;15(8):2046-2064. doi: 10.1002/1878-0261.12964. Epub 2021 May 18.

Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome-wide in vivo shRNA screen was performed...

Cite
Sultan M, Nearing JT, Brown JM, et al. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Mol Oncol. 2021;15(8):2046-2064doi: 10.1002/1878-0261.12964.
Sultan, M., Nearing, J. T., Brown, J. M., Huynh, T. T., Cruickshank, B. M., Lamoureaux, E., Vidovic, D., Dahn, M. L., Fernando, W., Coyle, K. M., Giacomantonio, C. A., Langille, M. G. I., & Marcato, P. (2021). An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Molecular oncology, 15(8), 2046-2064. https://doi.org/10.1002/1878-0261.12964
Sultan, Mohammad, et al. "An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer." Molecular oncology vol. 15,8 (2021): 2046-2064. doi: https://doi.org/10.1002/1878-0261.12964
Sultan M, Nearing JT, Brown JM, Huynh TT, Cruickshank BM, Lamoureaux E, Vidovic D, Dahn ML, Fernando W, Coyle KM, Giacomantonio CA, Langille MGI, Marcato P. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Mol Oncol. 2021 Aug;15(8):2046-2064. doi: 10.1002/1878-0261.12964. Epub 2021 May 18. PMID: 33932086; PMCID: PMC8333778.
Copy Download .nbib Format: NLM
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer.

Molecular oncology

Sultan M, Nearing JT, Brown JM, Huynh TT, Cruickshank BM, Lamoureaux E, Vidovic D, Dahn ML, Fernando W, Coyle KM, Giacomantonio CA, Langille MGI, Marcato P.
PMID: 33932086
Mol Oncol. 2021 Aug;15(8):2046-2064. doi: 10.1002/1878-0261.12964. Epub 2021 May 18.

Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome-wide in vivo shRNA screen was performed...

Cite
Sultan M, Nearing JT, Brown JM, et al. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Mol Oncol. 2021;15(8):2046-2064doi: 10.1002/1878-0261.12964.
Sultan, M., Nearing, J. T., Brown, J. M., Huynh, T. T., Cruickshank, B. M., Lamoureaux, E., Vidovic, D., Dahn, M. L., Fernando, W., Coyle, K. M., Giacomantonio, C. A., Langille, M. G. I., & Marcato, P. (2021). An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Molecular oncology, 15(8), 2046-2064. https://doi.org/10.1002/1878-0261.12964
Sultan, Mohammad, et al. "An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer." Molecular oncology vol. 15,8 (2021): 2046-2064. doi: https://doi.org/10.1002/1878-0261.12964
Sultan M, Nearing JT, Brown JM, Huynh TT, Cruickshank BM, Lamoureaux E, Vidovic D, Dahn ML, Fernando W, Coyle KM, Giacomantonio CA, Langille MGI, Marcato P. An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Mol Oncol. 2021 Aug;15(8):2046-2064. doi: 10.1002/1878-0261.12964. Epub 2021 May 18. PMID: 33932086; PMCID: PMC8333778.
Copy Download .nbib Format: NLM
Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet.

The Journal of pediatrics

Ouattara A, Resseguier N, Cano A, De Lonlay P, Arnoux JB, Brassier A, Schiff M, Pichard S, Fabre A, Hoebeke C, Guffon N, Fouilhoux A, Broué P, Touati G, Dobbelaere D, Mention K, Labarthe F, Tardieu M, De Parscau L, Feillet F, Bonnemains C, Kuster A, Labrune P, Barth M, Damaj L, Lamireau D, Berbis J, Auquier P, Chabrol B.
PMID: 34788681
J Pediatr. 2021 Nov 14; doi: 10.1016/j.jpeds.2021.11.021. Epub 2021 Nov 14.

OBJECTIVE: To investigate the determinants of quality of life (QoL) in children with inborn errors of metabolism with restricted diet (IEMRDs) using a single theory-based multidimensional model.STUDY DESIGN: In this multicenter cross-sectional study, data from children with IEMRDs (except...

Cite
Ouattara A, Resseguier N, Cano A, et al. Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.11.021.
Ouattara, A., Resseguier, N., Cano, A., De Lonlay, P., Arnoux, J. B., Brassier, A., Schiff, M., Pichard, S., Fabre, A., Hoebeke, C., Guffon, N., Fouilhoux, A., Broué, P., Touati, G., Dobbelaere, D., Mention, K., Labarthe, F., Tardieu, M., De Parscau, L., Feillet, F., Bonnemains, C., Kuster, A., Labrune, P., Barth, M., Damaj, L., Lamireau, D., Berbis, J., Auquier, P., & Chabrol, B. (2021). Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.11.021
Ouattara, Abdoulaye, et al. "Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.11.021
Ouattara A, Resseguier N, Cano A, De Lonlay P, Arnoux JB, Brassier A, Schiff M, Pichard S, Fabre A, Hoebeke C, Guffon N, Fouilhoux A, Broué P, Touati G, Dobbelaere D, Mention K, Labarthe F, Tardieu M, De Parscau L, Feillet F, Bonnemains C, Kuster A, Labrune P, Barth M, Damaj L, Lamireau D, Berbis J, Auquier P, Chabrol B. Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. J Pediatr. 2021 Nov 14; doi: 10.1016/j.jpeds.2021.11.021. Epub 2021 Nov 14. PMID: 34788681.
Copy Download .nbib Format: NLM
Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System.

JAMA network open

Mikuls TR, Soto Q, Petro A, Helget L, Roul P, Sayles H, Cope B, Neogi T, LaMoreaux B, O'Dell JR, England BR.
PMID: 34989795
JAMA Netw Open. 2022 Jan 04;5(1):e2142347. doi: 10.1001/jamanetworkopen.2021.42347.

IMPORTANCE: Cardiometabolic and other risk factors could render patients with gout more likely to undergo lower extremity amputation (LEA).OBJECTIVE: To examine the rate of and factors associated with LEA in patients with gout.DESIGN, SETTING, AND PARTICIPANTS: In this matched...

Cite
Mikuls TR, Soto Q, Petro A, et al. Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System. JAMA Netw Open. 2022;5(1):e2142347doi: 10.1001/jamanetworkopen.2021.42347.
Mikuls, T. R., Soto, Q., Petro, A., Helget, L., Roul, P., Sayles, H., Cope, B., Neogi, T., LaMoreaux, B., O'Dell, J. R., & England, B. R. (2022). Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System. JAMA network open, 5(1), e2142347. https://doi.org/10.1001/jamanetworkopen.2021.42347
Mikuls, Ted R, et al. "Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System." JAMA network open vol. 5,1 (2022): e2142347. doi: https://doi.org/10.1001/jamanetworkopen.2021.42347
Mikuls TR, Soto Q, Petro A, Helget L, Roul P, Sayles H, Cope B, Neogi T, LaMoreaux B, O'Dell JR, England BR. Comparison of Rates of Lower Extremity Amputation in Patients With and Without Gout in the US Department of Veterans Affairs Health System. JAMA Netw Open. 2022 Jan 04;5(1):e2142347. doi: 10.1001/jamanetworkopen.2021.42347. PMID: 34989795.
Copy Download .nbib Format: NLM
Lamoreaux replies:.

Physical review letters

Lamoreaux SK.
PMID: 10991023
Phys Rev Lett. 2000 Jun 12;84(24):5673. doi: 10.1103/PhysRevLett.84.5673.

No abstract available.

Cite
Lamoreaux SK. Lamoreaux replies:. Phys Rev Lett. 2000;84(24):5673doi: 10.1103/PhysRevLett.84.5673.
Lamoreaux, S. K. (2000). Lamoreaux replies:. Physical review letters, 84(24), 5673. https://doi.org/10.1103/PhysRevLett.84.5673
Lamoreaux. "Lamoreaux replies:." Physical review letters vol. 84,24 (2000): 5673. doi: https://doi.org/10.1103/PhysRevLett.84.5673
Lamoreaux SK. Lamoreaux replies:. Phys Rev Lett. 2000 Jun 12;84(24):5673. doi: 10.1103/PhysRevLett.84.5673. PMID: 10991023.
Copy Download .nbib Format: NLM
Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study.

Rheumatology and therapy

Albert JA, Hosey T, LaMoreaux B.
PMID: 32720081
Rheumatol Ther. 2020 Sep;7(3):639-648. doi: 10.1007/s40744-020-00222-7. Epub 2020 Jul 27.

INTRODUCTION: Gout is a painful inflammatory condition caused by chronically elevated serum uric acid levels (sUA). When standard urate-lowering therapies fail/are not tolerated, uncontrolled gout (elevated sUA, subcutaneous tophi, chronic gouty arthritis, frequent flares) can occur. Pegloticase, a recombinant...

Cite
Albert JA, Hosey T, LaMoreaux B. Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study. Rheumatol Ther. 2020;7(3):639-648doi: 10.1007/s40744-020-00222-7.
Albert, J. A., Hosey, T., & LaMoreaux, B. (2020). Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study. Rheumatology and therapy, 7(3), 639-648. https://doi.org/10.1007/s40744-020-00222-7
Albert, John A, et al. "Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study." Rheumatology and therapy vol. 7,3 (2020): 639-648. doi: https://doi.org/10.1007/s40744-020-00222-7
Albert JA, Hosey T, LaMoreaux B. Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study. Rheumatol Ther. 2020 Sep;7(3):639-648. doi: 10.1007/s40744-020-00222-7. Epub 2020 Jul 27. PMID: 32720081; PMCID: PMC7410902.
Copy Download .nbib Format: NLM
Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature.

Case reports in medicine

Kaya EA, Carlson JD, Thomas CJ, Wagner AE, Fairbanks RK, Lamoreaux WT, Lee CM.
PMID: 32318112
Case Rep Med. 2020 Apr 07;2020:3938270. doi: 10.1155/2020/3938270. eCollection 2020.

We present a unique case of a patient simultaneously diagnosed with solitary fibrous tumor (SFT) and unrelated adenocarcinoma of the lung, both proven with separate pathology. It was subsequently found that the SFT had metastasized to the brain by...

Cite
Kaya EA, Carlson JD, Thomas CJ, et al. Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature. Case Rep Med. 2020;2020:3938270doi: 10.1155/2020/3938270.
Kaya, E. A., Carlson, J. D., Thomas, C. J., Wagner, A. E., Fairbanks, R. K., Lamoreaux, W. T., & Lee, C. M. (2020). Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature. Case reports in medicine, 20203938270. https://doi.org/10.1155/2020/3938270
Kaya, Erin A, et al. "Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature." Case reports in medicine vol. 2020 (2020): 3938270. doi: https://doi.org/10.1155/2020/3938270
Kaya EA, Carlson JD, Thomas CJ, Wagner AE, Fairbanks RK, Lamoreaux WT, Lee CM. Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature. Case Rep Med. 2020 Apr 07;2020:3938270. doi: 10.1155/2020/3938270. eCollection 2020. PMID: 32318112; PMCID: PMC7166291.
Copy Download .nbib Format: NLM
Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Chabrol B, Jacquin P, Francois L, Broué P, Dobbelaere D, Douillard C, Dubois S, Feillet F, Perrier A, Fouilhoux A, Labarthe F, Lamireau D, Mazodier K, Maillot F, Mochel F, Schiff M, Belmatoug N.
PMID: 29914755
Arch Pediatr. 2018 Jun 15; doi: 10.1016/j.arcped.2018.05.009. Epub 2018 Jun 15.

Inherited metabolic diseases (IMD) form a heterogeneous group of genetic disorders that surface primarily during childhood and result in significant morbidity and mortality. A prevalence of 1 in 2500-5000 live births is often reported. The transfer of adolescents from...

Cite
Chabrol B, Jacquin P, Francois L, et al. Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M). Arch Pediatr. 2018;doi: 10.1016/j.arcped.2018.05.009.
Chabrol, B., Jacquin, P., Francois, L., Broué, P., Dobbelaere, D., Douillard, C., Dubois, S., Feillet, F., Perrier, A., Fouilhoux, A., Labarthe, F., Lamireau, D., Mazodier, K., Maillot, F., Mochel, F., Schiff, M., & Belmatoug, N. (2018). Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M). Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, . https://doi.org/10.1016/j.arcped.2018.05.009
Chabrol, B, et al. "Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M)." Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. (2018). doi: https://doi.org/10.1016/j.arcped.2018.05.009
Chabrol B, Jacquin P, Francois L, Broué P, Dobbelaere D, Douillard C, Dubois S, Feillet F, Perrier A, Fouilhoux A, Labarthe F, Lamireau D, Mazodier K, Maillot F, Mochel F, Schiff M, Belmatoug N. Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M). Arch Pediatr. 2018 Jun 15; doi: 10.1016/j.arcped.2018.05.009. Epub 2018 Jun 15. PMID: 29914755.
Copy Download .nbib Format: NLM
Using 3-6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores.

Nutrition & metabolism

Lands B, Lamoreaux E.
PMID: 22624598
Nutr Metab (Lond). 2012 May 24;9(1):46. doi: 10.1186/1743-7075-9-46.

BACKGROUND: The vitamin-like omega-3 and omega-6 essential fatty acids are converted in the body to a large family of hormones which act at selective receptors that occur on nearly every cell and tissue. A relative omega-3 deficit allows overabundant...

Cite
Lands B, Lamoreaux E. Using 3-6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores. Nutr Metab (Lond). 2012;9(1):46doi: 10.1186/1743-7075-9-46.
Lands, B., & Lamoreaux, E. (2012). Using 3-6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores. Nutrition & metabolism, 9(1), 46. https://doi.org/10.1186/1743-7075-9-46
Lands, Bill, and Lamoreaux, Etienne. "Using 3-6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores." Nutrition & metabolism vol. 9,1 (2012): 46. doi: https://doi.org/10.1186/1743-7075-9-46
Lands B, Lamoreaux E. Using 3-6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores. Nutr Metab (Lond). 2012 May 24;9(1):46. doi: 10.1186/1743-7075-9-46. PMID: 22624598; PMCID: PMC3533819.
Copy Download .nbib Format: NLM
Diffusivity of gases in liquids.

Proceedings of the National Academy of Sciences of the United States of America

Hildebrand JH, Lamoreaux RH.
PMID: 16592175
Proc Natl Acad Sci U S A. 1974 Sep;71(9):3321-4. doi: 10.1073/pnas.71.9.3321.

Diffusion coefficients of H(2), Ne, N(2), Ar, CH(4), Cl(2), CF(4), C(2)H(6), SF(6), I(2), and isotopic CCl(4), all in CCl(4), determined at atmospheric pressure, are linear functions of temperature, converging to zero at the temperature where CCl(4) ceases to be...

Cite
Hildebrand JH, Lamoreaux RH. Diffusivity of gases in liquids. Proc Natl Acad Sci U S A. 1974;71(9):3321-4doi: 10.1073/pnas.71.9.3321.
Hildebrand, J. H., & Lamoreaux, R. H. (1974). Diffusivity of gases in liquids. Proceedings of the National Academy of Sciences of the United States of America, 71(9), 3321-4. https://doi.org/10.1073/pnas.71.9.3321
Hildebrand, J H, and Lamoreaux, R H. "Diffusivity of gases in liquids." Proceedings of the National Academy of Sciences of the United States of America vol. 71,9 (1974): 3321-4. doi: https://doi.org/10.1073/pnas.71.9.3321
Hildebrand JH, Lamoreaux RH. Diffusivity of gases in liquids. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3321-4. doi: 10.1073/pnas.71.9.3321. PMID: 16592175; PMCID: PMC433762.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 100 entries